Cloning and expression of the rat nephrin homolog

被引:61
作者
Ahola, H
Wang, SX
Luimula, P
Solin, ML
Holzman, LB
Holthöfer, H
机构
[1] Univ Helsinki, Haartman Inst, Div Bacterial & Immunol, FIN-00014 Helsinki, Finland
[2] Univ Michigan, Div Nephrol, Dept Internal Med, Ann Arbor, MI 48109 USA
基金
芬兰科学院;
关键词
D O I
10.1016/S0002-9440(10)65190-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Despite of the increased availability of genetically modified mouse strains, the experimental models in the rat have provided the most widely employed and versatile models for the study of renal pathophysiology and functional genetics. The identification of the human gene mutated in the congenital nephrotic syndrome of the Finnish type (NPHS1) has recently been reported, and its protein product has been termed nephrin. Here we report the molecular cloning and characterization of rat nephrin cDNA, Rat nephrin cDNA has an open reading frame of 3705 bp, shows 82% sequence identity with human nephrin cDNA, and shows characteristic rat-specific splicing variants. The translated nucleotide sequence has 89% sequence identity at the amino acid level. The signal sequence, glycosylation, and cysteine localization patterns are nearly identical to those of human nephrin. As in the human, the rat nephrin transcript is expressed in a tissue-restricted pattern. Antipeptide antibodies raised to the intracellular nephrin-specific domain identified immunoreactivity exclusively within the rat kidney glomerulus by indirect immunofluorescence. Initial results with semiquantitative reverse transcriptase-polymerase chain reaction analysis showed a remarkable down-regulation of nephrin-specific mRNA in the puromycin nephrosis of the rat.
引用
收藏
页码:907 / 913
页数:7
相关论文
共 28 条
[1]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[2]  
GROGGEL GC, 1987, AM J PATHOL, V128, P521
[3]   Mechanisms of proteinuria: Vascular permeability factor in congenital nephrotic syndrome of the Finnish type [J].
Haltia, A ;
Solin, HL ;
Jalanko, H ;
Holmberg, C ;
Miettinen, A ;
Holthofer, H .
PEDIATRIC RESEARCH, 1996, 40 (05) :652-657
[4]  
HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660
[5]   MANAGEMENT OF CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE [J].
HOLMBERG, C ;
ANTIKAINEN, M ;
RONNHOLM, K ;
ALAHOUHALA, M ;
JALANKO, H .
PEDIATRIC NEPHROLOGY, 1995, 9 (01) :87-93
[6]   NEPHRON SEGMENT AND CELL-TYPE-SPECIFIC EXPRESSION OF GANGLIOSIDES IN THE DEVELOPING AND ADULT KIDNEY [J].
HOLTHOFER, H ;
REIVINEN, J ;
MIETTINEN, A .
KIDNEY INTERNATIONAL, 1994, 45 (01) :123-130
[7]   Altered gene expression and functions of mitochondria in human nephrotic syndrome [J].
Holthöfer, H ;
Kretzler, M ;
Haltia, A ;
Solin, ML ;
Taanman, JW ;
Schägger, H ;
Kriz, W ;
Kerjaschki, D ;
Schlöndorff, D .
FASEB JOURNAL, 1999, 13 (03) :523-532
[8]  
Holthofer H, 1996, AM J PATHOL, V149, P1009
[9]   INHIBITION OF VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR ACTIVITY BY AN ENDOGENOUSLY ENCODED SOLUBLE RECEPTOR [J].
KENDALL, RL ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10705-10709